Diagnostic Laboratory of Oklahoma LLC

Diagnostic Laboratory of Oklahoma LLC was paid $69.01M by Medicaid between Jan 2018 and Nov 2024, across 331 billing codes. Its largest line is 87801, Infectious agent detection by nucleic acid; amplified probe, multiple organisms — 10% of everything it billed.

33Billing provider infoDIAGNOSTIC LABORATORY OF OKLAHOMA LLC
OKLAHOMA CITY, OK 73114

33aNPI1770529513assigned 06/21/2006

33bProvider typeClinical Medical Laboratory

28Total paid$69.01M

24GClaims4,083,383

24DCodes billed331

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Oklahoma

Rank by total paid#1 of 46

Median peer was paid$248K

This provider vs. median278×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	428,136	$7.77M
2019	419,919	$6.81M
2020	446,982	$8.63M
2021	603,924	$11.66M
2022	748,745	$12.74M
2023	819,193	$12.40M
2024incomplete	616,484	$9.01M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	10%	111,339	109,310	$7.03M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	9.2%	81,812	79,195	$6.37M
80050	General health panel	7.2%	153,770	153,515	$4.99M
80081		4.4%	43,991	43,901	$3.02M
80061	Lipid panel	4.1%	233,374	232,672	$2.83M
80053	Comprehensive metabolic panel	3.2%	234,149	222,009	$2.24M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	3.1%	64,015	63,093	$2.12M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.1%	63,714	62,806	$2.11M
84443	Thyroid stimulating hormone (TSH)	2.6%	115,589	114,810	$1.77M
83036	Hemoglobin; glycosylated (A1C)	2.4%	188,494	188,041	$1.66M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.3%	227,800	213,161	$1.61M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.1%	54,773	54,223	$1.47M

319 more codes

88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.9%	54,426	$1.32M
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.8%	56,909	$1.23M
87086	Culture, bacterial; quantitative colony count, urine	1.6%	149,276	$1.10M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.5%	18,892	$1.05M
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.5%	32,795	$1.04M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.4%	28,590	$941K
87088		1.3%	120,469	$916K
87799		1.0%	6,434	$711K
80074		1.0%	16,451	$711K
86803		<1%	52,874	$678K
83013		<1%	10,712	$653K
84439		<1%	78,871	$646K
84403		<1%	25,121	$585K
87070		<1%	67,136	$533K
84702		<1%	37,825	$524K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	3,752	$519K
87902		<1%	2,135	$507K
82728		<1%	41,043	$503K
83655		<1%	43,387	$481K
86235		<1%	5,820	$462K
84481		<1%	29,814	$457K
87077		<1%	55,144	$437K
87522	Neg quan hep c or qual rna	<1%	9,950	$389K
83880		<1%	11,205	$388K
82670		<1%	13,881	$350K
87186		<1%	39,815	$332K
87511		<1%	9,859	$328K
82105		<1%	20,519	$318K
86480		<1%	5,433	$302K
85027		<1%	51,162	$301K
87081		<1%	48,938	$298K
83001		<1%	17,106	$287K
84153		<1%	17,022	$283K
83550		<1%	34,155	$269K
83970		<1%	7,194	$268K
86038		<1%	23,846	$261K
86376		<1%	19,017	$250K
84146		<1%	13,096	$232K
83540		<1%	37,753	$220K
84144		<1%	11,133	$210K
82677		<1%	9,183	$208K
82950		<1%	43,980	$192K
83002		<1%	10,823	$182K
82570		<1%	36,471	$171K
86140		<1%	36,232	$170K
80048	Basic metabolic panel (calcium, ionized)	<1%	21,736	$167K
86592		<1%	42,961	$166K
84402		<1%	6,945	$160K
82607		<1%	11,633	$159K
86696		<1%	7,907	$158K
83735		<1%	25,840	$156K
86780		<1%	12,766	$152K
87536		<1%	1,994	$152K
88142		<1%	8,078	$150K
88141		<1%	6,735	$150K
87340		<1%	15,888	$149K
81001		<1%	48,675	$140K
86787		<1%	10,919	$138K
87480		<1%	7,354	$135K
87660		<1%	7,345	$135K
87510		<1%	7,327	$135K
86336		<1%	9,204	$134K
84436		<1%	20,973	$130K
83525		<1%	12,505	$130K
82784		<1%	11,099	$128K
36415	Collection of venous blood by venipuncture	<1%	16,355	$127K
82043		<1%	23,856	$125K
86800		<1%	8,624	$124K
86665		<1%	3,642	$118K
86704		<1%	10,843	$118K
82652		<1%	3,214	$112K
82951		<1%	9,222	$109K
83520		<1%	6,337	$98K
86695		<1%	7,492	$98K
86708		<1%	8,578	$96K
82746		<1%	6,574	$88K
82247		<1%	18,906	$87K
80197		<1%	6,992	$87K
80069		<1%	10,999	$87K
84270		<1%	4,309	$84K
84480		<1%	6,466	$84K
86200		<1%	6,982	$82K
82248		<1%	17,784	$82K
86431		<1%	15,504	$80K
85060		<1%	3,611	$79K
85652		<1%	32,010	$78K
86706		<1%	8,046	$78K
83516		<1%	7,222	$77K
85610		<1%	19,718	$76K
84479		<1%	12,766	$74K
86762		<1%	5,274	$73K
86850		<1%	8,424	$72K
86039		<1%	7,040	$71K
86769		<1%	1,707	$71K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,455	$70K
87075		<1%	7,972	$69K
87209		<1%	4,155	$68K
84681		<1%	3,579	$67K
86757		<1%	1,638	$67K
85018		<1%	30,427	$66K
83690		<1%	10,346	$65K
86160		<1%	2,989	$63K
82627		<1%	3,104	$63K
86364		<1%	5,146	$61K
84550		<1%	14,677	$60K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	580	$58K
84305		<1%	2,908	$57K
83498		<1%	2,299	$57K
82977		<1%	8,561	$56K
86317		<1%	4,021	$54K
86812		<1%	2,353	$54K
80164		<1%	4,183	$52K
82533		<1%	3,460	$51K
82672		<1%	2,591	$51K
86225		<1%	4,065	$51K
80076		<1%	6,536	$49K
84156		<1%	14,733	$49K
84100		<1%	10,555	$45K
84460		<1%	9,343	$45K
86664		<1%	3,230	$45K
87427		<1%	4,063	$45K
82542		<1%	2,049	$44K
82550		<1%	7,298	$43K
86147		<1%	699	$43K
84134		<1%	3,238	$43K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,471	$42K
82785		<1%	2,776	$41K
82150		<1%	6,942	$41K
84445		<1%	894	$41K
85014		<1%	18,501	$40K
87449		<1%	3,674	$40K
87045		<1%	4,339	$38K
87512		<1%	937	$37K
83014		<1%	5,236	$37K
87177		<1%	4,095	$36K
87205		<1%	9,151	$36K
84450		<1%	7,266	$34K
86003		<1%	626	$34K
84703		<1%	4,938	$34K
86870		<1%	786	$34K
82397		<1%	2,399	$33K
86146		<1%	538	$33K
82274		<1%	2,213	$32K
87517		<1%	831	$32K
82952		<1%	8,862	$32K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,309	$31K
86021		<1%	2,270	$31K
83993		<1%	1,745	$31K
86671		<1%	1,426	$30K
85730		<1%	5,399	$30K
82024		<1%	853	$29K
84425		<1%	1,449	$27K
82140		<1%	1,997	$26K
80055		<1%	558	$26K
87529		<1%	448	$25K
86618		<1%	1,572	$24K
86705		<1%	2,189	$24K
87324		<1%	2,153	$24K
83615		<1%	4,226	$23K
80177		<1%	1,822	$22K
84154		<1%	1,344	$22K
86162		<1%	1,210	$22K
86360		<1%	524	$22K
86381		<1%	889	$21K
86666		<1%	849	$20K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	395	$20K
83021		<1%	1,179	$20K
82947		<1%	5,560	$20K
85041		<1%	7,253	$20K
83718		<1%	2,666	$20K
86036		<1%	1,795	$19K
87046		<1%	2,062	$19K
81025		<1%	2,486	$19K
86361		<1%	782	$19K
85651		<1%	4,880	$18K
86901		<1%	6,512	$18K
86900		<1%	6,492	$18K
84630		<1%	1,746	$18K
80178		<1%	2,911	$18K
82310		<1%	3,663	$17K
86255		<1%	1,481	$17K
82172		<1%	918	$17K
83020		<1%	1,471	$17K
87481		<1%	572	$17K
87329		<1%	1,508	$17K
84466		<1%	1,452	$17K
87210		<1%	3,233	$16K
86617		<1%	579	$16K
82040		<1%	3,670	$16K
85048		<1%	6,987	$16K
85246		<1%	714	$15K
84255		<1%	633	$15K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	478	$14K
84484		<1%	1,298	$14K
82626		<1%	636	$14K
82565		<1%	3,052	$14K
83921		<1%	748	$14K
87147		<1%	2,964	$14K
87493		<1%	414	$14K
82465		<1%	3,312	$13K
82103		<1%	1,080	$13K
85379		<1%	1,418	$13K
87338		<1%	946	$12K
84244		<1%	607	$12K
86015		<1%	1,157	$12K
87385		<1%	1,017	$12K
87076		<1%	1,435	$12K
84478		<1%	2,311	$12K
85613		<1%	1,161	$11K
84165		<1%	1,130	$11K
84075		<1%	2,291	$11K
82088		<1%	290	$11K
82390		<1%	1,046	$10K
86341		<1%	482	$10K
86593		<1%	2,517	$10K
84155		<1%	2,881	$10K
85045		<1%	2,470	$9K
87040		<1%	928	$9K
85240		<1%	561	$9K
84520		<1%	2,471	$9K
85245		<1%	426	$9K
87497		<1%	229	$9K
85660		<1%	1,694	$9K
82653		<1%	402	$8K
86709		<1%	806	$8K
86304		<1%	407	$8K
84295		<1%	1,724	$7K
81003		<1%	3,289	$7K
82164		<1%	518	$7K
85007		<1%	1,954	$7K
80175		<1%	553	$7K
87563		<1%	206	$6K
82374		<1%	1,409	$6K
81015		<1%	2,191	$6K
84590		<1%	584	$6K
87807		<1%	508	$6K
82435		<1%	1,428	$6K
86258		<1%	324	$6K
86060		<1%	835	$6K
82157		<1%	206	$5K
82085		<1%	600	$5K
83883		<1%	320	$5K
87653		<1%	128	$4K
86308		<1%	918	$4K
86334		<1%	207	$4K
84446		<1%	326	$4K
85004		<1%	655	$4K
82525		<1%	335	$4K
82787		<1%	142	$4K
83721		<1%	379	$4K
81596		<1%	56	$4K
83010		<1%	274	$4K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	82	$3K
83090		<1%	210	$3K
80185		<1%	253	$3K
82378		<1%	189	$3K
86337		<1%	170	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	194	$3K
86886		<1%	424	$3K
86765		<1%	231	$3K
87255		<1%	85	$3K
82330		<1%	212	$3K
80051		<1%	391	$2K
87625		<1%	61	$2K
87185		<1%	474	$2K
85597		<1%	135	$2K
80156		<1%	145	$2K
82575		<1%	210	$2K
82104		<1%	140	$2K
86753		<1%	160	$2K
84482		<1%	124	$2K
87420		<1%	139	$2K
86735		<1%	129	$2K
86645		<1%	104	$2K
83704		<1%	52	$2K
82530		<1%	95	$2K
86644		<1%	112	$2K
86738		<1%	59	$1K
86141		<1%	120	$1K
86301		<1%	70	$1K
86215		<1%	99	$1K
83519		<1%	70	$1K
89055		<1%	299	$1K
87634		<1%	17	$1K
83695		<1%	83	$1K
36416		<1%	385	$1K
80165		<1%	80	$963.20
80202		<1%	74	$930.29
83835		<1%	53	$799.21
84432		<1%	54	$771.66
87300		<1%	65	$764.35
87400		<1%	31	$754.54
82610		<1%	44	$707.00
85598		<1%	42	$671.58
86682		<1%	53	$613.21
83521		<1%	40	$599.04
80183		<1%	41	$483.39
86000		<1%	71	$458.98
84166		<1%	28	$444.08
80299		<1%	27	$431.41
87425		<1%	40	$426.40
86355		<1%	12	$402.72
86359		<1%	12	$402.72
83003		<1%	12	$313.80
85247		<1%	14	$285.60
87206		<1%	59	$282.61
87350		<1%	24	$246.24
84132		<1%	54	$228.72
87101		<1%	27	$211.14
86774		<1%	16	$210.56
86256		<1%	13	$159.12
87276		<1%	12	$158.64
84597		<1%	12	$146.40
87275		<1%	12	$146.04
87220		<1%	31	$134.23
82553		<1%	13	$133.51
87184		<1%	14	$91.41
82272		<1%	17	$60.86
85049		<1%	19	$46.73

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMULLEN, R'NEE (CEO)

Parent organizationQUEST DIAGNOSTICS INCORPORATED